相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti-COVID-19 Treatments
Safa Daoud et al.
MEDICINAL CHEMISTRY (2022)
Elaboration of Novel TTK1 Inhibitory Leads via QSAR-Guided Selection of Crystallographic Pharmacophores Followed By In Vitro Assay
Mahmoud A. Al-Sha'er et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
Prediction of activity cliffs on the basis of images using convolutional neural networks
Javed Iqbal et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2021)
Broad-scale analysis of thermodynamic signatures in medicinal chemistry: are enthalpy-favored binders the better development option?
Gerhard Klebe
DRUG DISCOVERY TODAY (2019)
Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods
Ghada Omar Tuffaha et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations
Gleb Solomentsev et al.
BIOCHEMISTRY (2018)
Paradoxically, Most Flexible Ligand Binds Most Entropy-Favored: Intriguing Impact of Ligand Flexibility and Solvation on Drug-Kinase Binding
Barbara Wienen-Schmidt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor
Mahmoud A. Al-Sha'er et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors
Jason G. Kettle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Intrinsic Thermodynamics and Structures of 2,4-and 3,4-Substituted Fluorinated Benzenesulfonamides Binding to Carbonic Anhydrases
Asta Zubriene et al.
CHEMMEDCHEM (2017)
Docking-based comparative intermolecular contacts analysis and in silico screening reveal new potent acetylcholinesterase inhibitors
Maha Habash et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Protein conformational flexibility modulates kinetics and thermodynamics of drug binding
M. Amaral et al.
NATURE COMMUNICATIONS (2017)
Soaking suggests alternative facts : Only cocrystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition
Frederik Rainer Ehrmann et al.
PLOS ONE (2017)
Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads
Rua'a A. Al-Aqtash et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2017)
A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis
Guido Bold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Water, water, everywhere ... It's time to stop and think
Michael S. Bodnarchuk
DRUG DISCOVERY TODAY (2016)
Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors
Dana A. AlQudah et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation
Shada J. Alabed et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Understanding the Roles of the Two QSARs
Toshio Fujita et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies
Ma'mon M. Hatmal et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2016)
Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation
Mahmoud A. Al-Sha'er et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Identification of Interaction Hot Spots in Structures of Drug Targets on the Basis of Three-Dimensional Activity Cliff Information
Norbert Furtmann et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Structure-Based Predictions of Activity Cliffs
Jarmila Husby et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Exploring Free Energy Landscapes of Large Conformational Changes: Molecular Dynamics with Excited Normal Modes
Mauricio G. S. Costa et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Ligand-based modeling followed by in vitro bioassay yielded new potent glucokinase activators
Mutasem O. Taha et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
Lingle Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models
Nuria Plattner et al.
NATURE COMMUNICATIONS (2015)
Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization
Kiyoshi Okamoto et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The design and discovery of water soluble 4-substituted-2, 6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents
Xin Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Free Energy Calculations to Estimate Ligand-Binding Affinities in Structure-Based Drug Design
M. Rami Reddy et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis
Mutasem O. Taha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors
Lei Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Rationalization of Activity Cliffs of a Sulfonamide Inhibitor of DNA Methyltransferases with Induced-Fit Docking
Jose L. Medina-Franco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Accuracy Assessment and Automation of Free Energy Calculations for Drug Design
Clara D. Christ et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Composition and Topology of Activity Cliff Clusters Formed by Bioactive Compounds
Dagmar Stumpfe et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Elaborate ligand-based modeling reveals new human neutrophil elastase inhibitors
Maha Habash et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
Molecular Dynamics Simulation Study of Conformational Changes of Transcription Factor TFIIS during RNA Polymerase II Transcriptional Arrest and Reactivation
Changsun Eun et al.
PLOS ONE (2014)
Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII
Migle Kisonaite et al.
PLOS ONE (2014)
Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor
Naoki Miyamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents
Aleem Gangjee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Collinearity: a review of methods to deal with it and a simulation study evaluating their performance
Carsten F. Dormann et al.
ECOGRAPHY (2013)
Prediction of Individual Compounds Forming Activity Cliffs Using Emerging Chemical Patterns
Vigneshwaran Namasivayam et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Elaborate Ligand-Based Modeling Coupled with Multiple Linear Regression and k Nearest Neighbor QSAR Analyses Unveiled New Nanomolar mTOR Inhibitors
Mohammad A. Khanfar et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Free Energy Calculations Reveal the Origin of Binding Preference for Aminoadamantane Blockers of Influenza A/M2TM Pore
Paraskevi Gkeka et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors
Sawsan Abuhamdah et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
VEGFA and tumour angiogenesis
L. Claesson-Welsh et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors
Mahmoud A. Al-Sha'er et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2013)
Ligand-based pharmacophore exploration and QSAR analysis of transition state analogues followed by in silico screening guide the discovery of new sub-micromolar β-secreatase inhibitors
Afaf Al-Nadaf et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Designing Molecular Dynamics Simulations to Shift Populations of the Conformational States of Calmodulin
Ayse Ozlem Aykut et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads
Rand Shahin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors
Takashi Chiba et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Searching for Coordinated Activity Cliffs Using Particle Swarm Optimization
Vigneshwaran Namasivayam et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Prediction of Activity Cliffs Using Support Vector Machines
Kathrin Heikamp et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Extending the Activity Cliff Concept: Structural Categorization of Activity Cliffs and Systematic Identification of Different Types of Cliffs in the ChEMBL Database
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors
Rand Shahin et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives
Mark H. Norman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Exploring Activity Cliffs in Medicinal Chemistry Miniperspective
Dagmar Stumpfe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design and Synthesis of Novel DFG-Out RAF/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Inhibitors. 1. Exploration of [5,6]-Fused Bicyclic Scaffolds
Masanori Okaniwa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
Michele McTigue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases
Hidehisa Iwata et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Exploring structure-activity data using the landscape paradigm
Rajarshi Guha
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2012)
Signal Transduction by Vascular Endothelial Growth Factor Receptors
Sina Koch et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Ligand-induced fit affects binding modes and provokes changes in crystal packing of aldose reductase
Cornelia Koch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
Discovery of New Antifungal Leads via Pharmacophore Modeling and QSAR Analysis of Fungal N-Myristoyl Transferase Inhibitors Followed by In Silico Screening
Mutasem O. Taha et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
From Activity Cliffs to Target-Specific Scoring Models and Pharmacophore Hypotheses
Birte Seebeck et al.
CHEMMEDCHEM (2011)
Contribution of Explicit Solvent Effects to the Binding Affinity of Small-Molecule Inhibitors in Blood Coagulation Factor Serine Proteases
Robert Abel et al.
CHEMMEDCHEM (2011)
Ligand - based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks
Antreas Afantitis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
From Activity Cliffs to Activity Ridges: Informative Data Structures for SAR Analysis
Martin Vogt et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation
Yuya Oguro et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration
Reema Abu Khalaf et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets
Jameed Hussain et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields
K. Vanommeslaeghe et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
QM/MM Methods for Biomolecular Systems
Hans Martin Senn et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase
Victor J. Cee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors
Areej M. Abu Hammad et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors
Georgia Melagraki et al.
MOLECULAR DIVERSITY (2009)
IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
R. Z. Cer et al.
NUCLEIC ACIDS RESEARCH (2009)
Discovery of amido-benzisoxazoles as potent c-Kit inhibitors
Roxanne K. Kunz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Assessing how well a modeling protocol captures a structure-activity landscape
Rajarshi Guha et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - What can we learn from earlier mistakes?
Johannes Kirchmair et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2008)
Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis
Daniel S. La et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Discovery of aryl aminoquinazoline pyridones as potent selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit
Essa Hu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors
Matthew M. Weiss et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Combining Ligand-Based Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis and in Silico Screening for the Discovery of New Potent Hormone Sensitive Lipase Inhibitors
Mutasem O. Taha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide (pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: Design, synthesis, and evaluations
Jean-Christophe Harmange et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Novel anti-angiogenic therapies for malignant gliomas
Andrew D. Norden et al.
LANCET NEUROLOGY (2008)
Development and evaluation of a QSPR model for the prediction of diamagnetic susceptibility
Antreas Afantitis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
SAR index: Quantifying the nature of structure - Activity relationships
Lisa Peltason et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Tracing changes in protonation: A prerequisite to factorize thermodynamic data of inhibitor binding to aldose reductase
Holger Steuber et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Discovery of novel Benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors
Masaichi Hasegawa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Design, synthesis, and evaluation of orally active Benzimidazoles and Benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
Michele H. Potashman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
QSRR: Quantitative Structure-(Chromatographic) retention relationships
Roman Kaliszan
CHEMICAL REVIEWS (2007)
Water, water everywhere - except where it matters?
Steve W. Homans
DRUG DISCOVERY TODAY (2007)
Hypoxia: A key regulator of angiogenesis in cancer
Debbie Liao et al.
CANCER AND METASTASIS REVIEWS (2007)
Anion binding involving π-acidic heteroaromatic rings
Patrick Gamez et al.
ACCOUNTS OF CHEMICAL RESEARCH (2007)
Structural and thermodynamic study on aldose reductase: Nitro-substituted inhibitors with strong enthalpic binding contribution
Holger Steuber et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Pharmacophore modeling and in silico screening for new KDR kinase inhibitors
Hui Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening
Mutasem O. Taha et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2007)
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine tie-2 kinase inhibitor
Brian L. Hodous et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Thermodynamic inhibition profile of a cyclopentyl and a cyclohexyl derivative towards thrombin: The same but for different reasons
Christof Gerlach et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Interpreting steep dose-response curves in early inhibitor discovery
Brian K. Shoichet
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding
Julian Tirado-Rives et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A novel automated lazy learning QSAR (ALL-QSAR) approach: Method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models
Shuxing Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Angiogenesis in cancer
Naoyo Nishida et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
S Faivre et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
YJ Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Large-scale validation of a quantum mechanics based scoring function: Predicting the binding affinity and the binding mode of a diverse set of protein-ligand complexes
K Raha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors
Y Miyazaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective
K Paz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Virtual screening workflow development guided by the receiver operating characteristic curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4
N Triballeau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors
PA Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Comparative analysis of protein-bound ligand conformations with respect to catalyst's conformational space subsampling algorithms
J Kirchmair et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Pharmacophore modeling and three dimensional database searching for drug design using catalyst:: Recent advances
O Güner et al.
CURRENT MEDICINAL CHEMISTRY (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Designing screens: How to make your hits a hit
WP Walters et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Crucial problems in regression modelling and their solutions
M Meloun et al.
ANALYST (2002)
Pharmacophore modeling and three-dimensional database searching for drug design using catalyst
Y Kurogi et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Novel variable selection quantitative structure-property relationship approach based on the k-nearest-neighbor principle
WF Zheng et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2000)